As of 2025-12-18, the Relative Valuation of Gossamer Bio Inc (GOSS) is (5.83) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.57 USD, the upside of Gossamer Bio Inc based on Relative Valuation is -263.4%.
The range of the Relative Valuation is (2.35) - (9.28) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.4x - 13.8x | 8.6x |
| Forward P/E multiples | 3.5x - 13.9x | 8.7x |
| Fair Price | (2.35) - (9.28) | (5.83) |
| Upside | -165.8% - -360.0% | -263.4% |
| Date | P/E |
| 2025-12-15 | -5.62 |
| 2025-12-12 | -5.34 |
| 2025-12-11 | -5.37 |
| 2025-12-10 | -5.17 |
| 2025-12-09 | -5.11 |
| 2025-12-08 | -5.06 |
| 2025-12-05 | -4.94 |
| 2025-12-04 | -4.92 |
| 2025-12-03 | -5.07 |
| 2025-12-02 | -4.43 |
| 2025-12-01 | -4.65 |
| 2025-11-28 | -4.95 |
| 2025-11-26 | -4.95 |
| 2025-11-25 | -4.85 |
| 2025-11-24 | -4.71 |
| 2025-11-21 | -4.54 |
| 2025-11-20 | -4.61 |
| 2025-11-19 | -4.65 |
| 2025-11-18 | -4.52 |
| 2025-11-17 | -4.43 |
| 2025-11-14 | -4.02 |
| 2025-11-13 | -3.72 |
| 2025-11-12 | -4.00 |
| 2025-11-11 | -3.84 |
| 2025-11-10 | -3.68 |
| 2025-11-07 | -3.50 |
| 2025-11-06 | -3.42 |
| 2025-11-05 | -3.51 |
| 2025-11-04 | -3.41 |
| 2025-11-03 | -3.54 |
| 2025-10-31 | -3.63 |
| 2025-10-30 | -3.59 |
| 2025-10-29 | -3.54 |
| 2025-10-28 | -3.53 |
| 2025-10-27 | -3.54 |
| 2025-10-24 | -3.68 |
| 2025-10-23 | -3.10 |
| 2025-10-22 | -3.28 |
| 2025-10-21 | -3.23 |
| 2025-10-20 | -3.37 |
| 2025-10-17 | -3.25 |
| 2025-10-16 | -3.42 |
| 2025-10-15 | -3.57 |
| 2025-10-14 | -3.53 |
| 2025-10-13 | -3.62 |
| 2025-10-10 | -3.38 |
| 2025-10-09 | -3.80 |
| 2025-10-08 | -3.59 |
| 2025-10-07 | -3.71 |
| 2025-10-06 | -3.57 |